Sign in

Hannes Hagström

@liverepi.bsky.social
486 followers 129 following 35 posts

Professor in gastroenterology and hepatology @KarolinskaInst. Adjunct editor @JInternMed. Interest in liver disease, especially MASLD/MASH, public health, epidemiology.

PostsRepliesMedia
Reposted by Hannes Hagström
ghadanouairia.bsky.social @ghadanouairia.bsky.social · 08/12/2025
We’re recruiting a PhD student in AI + Cancer Research at Karolinska Institutet! This is your chance to work in clinical hepatology, multi-omics, and machine learning. Please share and tag! lnkd.in/dR5j3cxZ #PhDPosition #AIinMedicine #CancerResearch #Bioinformatics #KarolinskaInstitutet
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
041
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 17/10/2025
New review from researchers at #Karolinskainstitutet! Health inequalities in the Nordic countries: A comparative overview and update 🔗https://doi.org/10.1111/joim.70029 #healthinequality #mortality
011
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 17/10/2025
New Original Article! Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement 🔗https://doi.org/10.1111/joim.70030 #FPR1 #rheumatoidarthritis #interstitiallungdisease #mitochondria
022
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 17/10/2025
New Original Article to read! Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk 🔗https://doi.org/10.1111/joim.70026 #IBD #PSC #colorectalcancer #livertransplant
011
Reposted by Hannes Hagström
Otto English @ottoenglish.bsky.social · 27/09/2025
Nathan Gill is no fringe politician. He was the leader of the Reform Party and before that UKIP in Wales. A Brexit Party MEP. A friend and ally of Nigel Farage, who in 2016 called him: "terrific," and "as honest as the day is long." This is a MASSIVE story www.bbc.co.uk/news/article...
bbc.co.uk
Reform UK's ex-Wales leader Nathan Gill admits pro-Russia bribery
Nathan Gill admits eight charges of bribery while being a Member of the European Parliament.
18435261993
Reposted by Hannes Hagström
Dr Ellie Murray, ScD @epiellie.bsky.social · 12/07/2025
A man in Arizona just died from pneumonic plague. Before you freak out, here are 5 things you need to know about plague. LInk: open.substack.com/pub/epiellie...
open.substack.com
Plague Death in Arizona: 5 Things you Need to Know
Yesterday, Coconino County, Arizona reported the death of a man from pneumonic plague.
37432
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 04/07/2025
Welcome to read the Editor´s Choice in July! ➡️Accumulating understanding that diet, stress, toxins, and infections affect offspring health. 🔗 doi.org/10.1111/joim.20094 👉Also, read the July issue: onlinelibrary.wiley.com/toc/13652796/2025/298/1 #epigenetics #inflammatorymemory
021
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 04/07/2025
New Review Article to read! Gaucher disease, state of the art and perspectives #gaucherdisease #glucocerebrosidase #lysosomes 🔗Read here: doi.org/10.1111/joim...
011
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 02/07/2025
New Editorial! Community prevalence of advanced liver fibrosis in Type 2 diabetes—How big is the challenge? #MASLD #T2D 🔗 doi.org/10.1111/joim... 👉This Editorial comments on: doi.org/10.1111/joim...
doi.org
<em>Journal of Internal Medicine</em> | Wiley Online Library
Click on the article title to read more.
021
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 18/06/2025
Read the News Release! Fatty liver – but not liver damage – common in type 2 diabetes | EurekAlert! www.eurekalert.org/news-release...
eurekalert.org
Fatty liver – but not liver damage – common in type 2 diabetes
Six out of ten people with type 2 diabetes had fatty liver in a new study from Link&ouml;ping University in Sweden. Of these, only a small percentage had developed more severe liver disease. The study...
032
Hannes Hagström @liverepi.bsky.social · 06/06/2025
New review from us: Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin Deficiency. Happy to coauthor with leading experts and led by Joost Boeckmans. Nice start of a new project on AATD using Swedish data. onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Clinical Utility of Non‐Invasive Tests for Liver Fibrosis in People Living With Alpha‐1 Antitrypsin Deficiency
Severe alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition characterised by low systemic levels of alpha-1 antitrypsin due to its retention in the liver. Consequently, it predisposes in...
100
Reposted by Hannes Hagström
Doctors Without Borders / Médecins Sans Frontières (MSF) @msf.ca · 05/06/2025
Our medical staff are donating their own blood to provide life-saving treatment for patients in #Gaza. Patients that were gunned down while trying to get food. Food for their families. Food to live. We need an immediate #ceasefire, now.
2285185
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 20/05/2025
Continuing today! The 19th Key symposium 2025: Planetary Health – connect the dots. What saves the planet saves our health! 19-21 May in Stockholm, Sweden. Gunhild Stordalen opens today´s program: key-symposium2025.se #PlanetaryHealth25
021
Hannes Hagström @liverepi.bsky.social · 02/05/2025
Pretty cool study pubmed.ncbi.nlm.nih.gov/40309768/
pubmed.ncbi.nlm.nih.gov
Weight loss in MASLD restores the balance of liver fatty acid sources - PubMed
BACKGROUNDLipogenesis contributes substantially to the pathological accumulation of intrahepatic triacylglycerol (IHTG) in metabolic dysfunction-associated steatotic liver disease (MASLD). Since hepat...
010
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 28/04/2025
The May issue is now online! 👉Read our latest articles! 🔗 onlinelibrary.wiley.com/toc/13652796/2025/297/5 #medtwitter #cardiovascular #SGLT2 #diabetes #osteoporosis #Addisson #kidneycancer #hypertension #CKD
021
Reposted by Hannes Hagström
Matthias Löhr ʚїɞ @maloehr.bsky.social · 24/04/2025
The #JSGE @myueg.bsky.social symposium with #lenakristinconradi and @liverepi.bsky.social on using a metabolic switch in #pancreaticcancer for therapy and #MASLD respectively. Truly worth their #risingstar awards!
022
Hannes Hagström @liverepi.bsky.social · 13/04/2025
🚨New paper from us in Journal of Hepatology - Using PEth values on >50,000 persons to predict outcomes. www.sciencedirect.com/science/arti...
sciencedirect.com
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
Phosphatidylethanol (PEth) is an ethanol metabolite used as a specific biomarker for recent alcohol consumption. We aimed to determine the proportion …
1113
Reposted by Hannes Hagström
Rob Brierley @robbrierley.bsky.social · 09/04/2025
FDA approves first therapy for IgG4-related disease www.medscape.com/viewarticle/... #GastroSky #MedSky #RheumSky
medscape.com
FDA Approves First and Only Therapy for IgG4-RD
The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial.
061
Reposted by Hannes Hagström
Elin Bjarnegård @elinbja.bsky.social · 08/04/2025
Are you a researcher active outside of Europe who might consider coming to Sweden? Check out this @vetenskapsradet.bsky.social grant for recruitment of international visiting researchers! www.vr.se/english/appl...
vr.se
Grant for recruiting international visiting researchers to Sweden
The purpose of the grant is to provide higher education institutions and other research organisations the opportunity to develop and strengthen a research field by recruiting a distinguished researche...
086
Hannes Hagström @liverepi.bsky.social · 08/04/2025
Vote for Peter Stenvinkel as a "Sommar" radio show host: www.sverigesradio.se/artikel/kand... Would be such a nice experience!
sverigesradio.se
7. Den smarta naturen – Peter Stenvinkel - Sommar & Vinter i P1
Utmaningarna vår värld står inför tycks oändliga. Men tänk om det inte är så? I detta Sommarprat får vi lära oss hur vi med hjälp av forskning, naturens ...
000
Hannes Hagström @liverepi.bsky.social · 26/03/2025
New from Juan Vaz in our group: www.sciencedirect.com/science/arti... In >5400 patients with primary liver cancer (HCC), those with lower socio-economic parameters such as income levels have more advanced tumors at diagnosis, less frequently receive curative treatments and have poorer prognosis.
sciencedirect.com
Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study evaluates how strongly socioeconomic factors assoc…
021
Hannes Hagström @liverepi.bsky.social · 24/03/2025
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016... Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
journal-of-hepatology.eu
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...
1176
Hannes Hagström @liverepi.bsky.social · 21/03/2025
Interesting study from Alina Allen's group: pubmed.ncbi.nlm.nih.gov/40105977/ Reassuring that MASLD diagnosis identified through screening led to weight loss and no major issues with increased anxiety.
pubmed.ncbi.nlm.nih.gov
Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease - PubMed
Screening for diseases can have psychological impacts, such as anxiety, and requires acceptability from the population to be effective. This study examined the perspectives on the benefits and harms o...
130
Hannes Hagström @liverepi.bsky.social · 18/03/2025
April number of @jinternmed.bsky.social now out: onlinelibrary.wiley.com/toc/13652796...
onlinelibrary.wiley.com
<em>Journal of Internal Medicine</em> | Wiley Online Library
Click on the title to browse this issue
010
Reposted by Hannes Hagström
EASL @easlnews.bsky.social · 17/03/2025
Have you secured your spot for #EASLCongress 2025 on 7-10 May? 🌍Join us in Amsterdam or online to transform liver care worldwide! easlcongress.eu/2025-registr... 📜The deadline to submit your late-breaker abstract is TODAY, 17 March! easlcongress.eu/2025-abstrac...
052
Hannes Hagström @liverepi.bsky.social · 17/03/2025
Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis: pubmed.ncbi.nlm.nih.gov/40089069/ Interesting. Time for a RCT? #liversky @jhepatology.bsky.social
pubmed.ncbi.nlm.nih.gov
Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis - PubMed
LTSG results in sustained weight loss, resolution of diabetes and hypertension, and reduced recurrence of steatosis and possibly fibrosis compared to LT alone. It confers no increase in mortality or g...
020
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 28/02/2025
The March issue is now online! 👉 Read our latest articles! 🔗 onlinelibrary.wiley.com/toc/13652796/2025/297/3 #sHLH #MRI #metabolicsyndrome #BreastCancer #liverdisease #lungcancer #Lithium #AATD #COVID #atrialfibrillation #obesity #personalizedmedicine
011
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 05/03/2025
New article to read! Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality. ➡️ A meta-analysis ➡️ Lower incidence of all-cause mortality ➡️ Higher incidence of adverse events 🔗 doi.org/10.1111/joim.20078 #hypertension #antihypertensives
011
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 10/03/2025
New review to read! Current challenges in lung transplantation. ➡️ The importance of continued advancements in donor management ➡️ Organ preservation ➡️ Perioperative care to ultimately improve outcomes for lung transplant recipients 🔗 doi.org/10.1111/joim.20072
021
Reposted by Hannes Hagström
Seth Abramson @sethabramson.bsky.social · 02/03/2025
As Donald Trump turns the United States into one of the closest allies Russia has worldwide, it's worth revisiting the news item below, which came out immediately after Trump won a surprising victory in November:
18444022372
Reposted by Hannes Hagström
Drug Monkey @drugmonkey.bsky.social · 02/03/2025
Reminder that Europepmc.org exists. In case anyone should need it for any reason.
europepmc.org
Europe PMCHome - Europe PMC
Europe PMC is an archive of life sciences journal literature.
5266120
Hannes Hagström @liverepi.bsky.social · 20/02/2025
New research letter from our newest group member PhD-student Merle Roeren et al in @jhepatology.bsky.social . We use data on liver tests in patients with type 2 diabetes to examine how screening with FIB4 would play out IRL... (continued.)
120
Hannes Hagström @liverepi.bsky.social · 16/02/2025
New review from us led by PhD-student dr Hanne Åström - Psychosocial risks in MASLD. We discuss socioeconomic disparities, risk for depression and anxiety and quality of life studies - and much more. Check it out: pubmed.ncbi.nlm.nih.gov/39953908/
pubmed.ncbi.nlm.nih.gov
Psychosocial risks in Metabolic dysfunction-associated steatotic liver disease - PubMed
Persons with MASLD often experience psychosocial adversities that may be expressed as lower SES, high prevalence of depression, and reduced QoL. Knowledge gaps remain regarding the association between...
020
Hannes Hagström @liverepi.bsky.social · 16/02/2025
New from us: Comparing rates of decompensation/HCC in patients with ALD and MASLD cirrhosis using register data. Quite similar! pubmed.ncbi.nlm.nih.gov/39952814/ Thanks to first author Joost Boeckmans and the rest of the team. #liversky #MASLD #ALD @ki.se
180
Hannes Hagström @liverepi.bsky.social · 11/02/2025
medevents.se/events/avl-2... Webinar (in Swedish) on ammonia tests in liver disease. Should be interesting!
medevents.se
Medevents - Ammoniumjon vid leversjukdom
010
Reposted by Hannes Hagström
Bernadette Moore @themoorelab.bsky.social · 02/02/2025
You Guys. This is *mesmerising*. What a speech. Worth watching in its entirety. He has his critics, but I am going to miss this articulate, intelligent leader on the world stage. Bravo 🇨🇦 🍁 🇨🇦 #Leadership
041
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 30/01/2025
New editorial! Intercontinentally validated diagnostic criteria for secondary hemophagocytic lymphohistiocytosis — So welcome! ➡️ #HLH may have various possible causes ➡️ Search for the underlying trigger(s) 🔗 doi.org/10.1111/joim.20066 ➡️ Commenting on: doi.org/10.1111/joim.20065
021
Reposted by Hannes Hagström
United European Gastroenterology @myueg.bsky.social · 21/01/2025
UEG is looking for 4 enthusiastic young GIs to join our Young Talent Group! Join the YTG & support the next generation of digestive health specialists in becoming experts in research and clinical practice! Learn more & apply now: bit.ly/3GKVuOz #weareUEG
a group of people posing for a photo
012
Reposted by Hannes Hagström
Maria Feychting @mfeychting.bsky.social · 21/01/2025
Opportunity! We are recruiting: Professor of Environmental Epidemiology Institute of Environmental Medicine, Karolinska Institutet ki.varbi.com/en/what:job/...
ki.varbi.com
Professor in Environmental Epidemiology
- with focus on research   Do you want to contribute to improving human health? The Institute of Environmental Medicine (IMM) is a department at Karolinska Institutet and an interdisciplinary researc
021
Hannes Hagström @liverepi.bsky.social · 18/01/2025
Modelling study suggests MASLD will cause 2.4% of all deaths in the US in 2050: jamanetwork.com/journals/jam... Time to act!
jamanetwork.com
Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease, 2020 to 2050
This decision analytical modeling study estimates the burden of metabolic dysfunction–associated steatotic liver disease among US adults from 2020 to 2050.
010
Reposted by Hannes Hagström
Karolinska Institutet @ki.se · 10/01/2025
Patients with celiac disease face an increased risk of developing any chronic liver disease. The relative risk for autoimmune liver disease was almost five times higher. Published in Lancet Regional Health – Europe. news.ki.se/celiac-disea...
172
Hannes Hagström @liverepi.bsky.social · 08/01/2025
New from us: Prognosis in alpha-1 antitrypsin deficiency (AATD). Out now in JIM - Journal of Internal Medicine: doi.org/10.1111/joim.... Briefly, we identified 2,286 patients with a diagnosis of AATD and compared selected outcomes to matched reference individuals from the general population.
doi.org
<em>Journal of Internal Medicine</em> | Wiley Online Library
Objective To estimate the incidence, prevalence, and outcomes of patients with diagnosed alpha-1-antitrypsin deficiency (AATD) in Sweden, 2002–2020. Study design and setting The Swedish National P.....
130
Hannes Hagström @liverepi.bsky.social · 03/01/2025
Nice attention to the liver in the guardian: www.theguardian.com/lifeandstyle... Would love to see more coverage in Swedish media on this as well!
theguardian.com
Love your liver! 19 simple ways to look after this incredible organ, chosen by doctors
Should you do Dry January? Is any amount of alcohol good for you? And do detoxes work? Experts reveal the tips they live by
071
Reposted by Hannes Hagström
Tanja Pyhäjärvi @pyhatanja.bsky.social · 16/12/2024
Big news from Finnish publication forum. Almost all MDPI and Frontiers journals will be downgraded to level 0 and thus are not considered as properly peer reviewed trustworthy scientific journals. julkaisufoorumi.fi/en/news/chan...
julkaisufoorumi.fi
Changes to the classification
18403273
Reposted by Hannes Hagström
Journal of Internal Medicine @jinternmed.bsky.social · 13/12/2024
The January issue is now online! Read our latest articles! 🔗 onlinelibrary.wiley.com/toc/13652796...
021
Hannes Hagström @liverepi.bsky.social · 13/12/2024
New from us: Screening for advanced fibrosis due to MASLD in T2D - the SCANDIA study. Out now in @LancetGastroHep: authors.elsevier.com/a/1kFtR8nByr... What did we do and find? Summarized in this thread:
authors.elsevier.com
193
Hannes Hagström @liverepi.bsky.social · 10/12/2024
New paper from us: onlinelibrary.wiley.com/doi/10.1111/... Consequences of alcohol often come hand in hand. Here, we show that around 10% of patients with alcohol-related liver disease at some point in their lives will also be diagnosed with acute pancreatitis.
173
Hannes Hagström @liverepi.bsky.social · 06/12/2024
Our group will present at an #ISPOR webinar Dec 10 about #MASLD and new data related to long-term health and economic outcomes. Sign up here: www.ispor.org/conferences-...
ispor.org
MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data
In this webinar, we explore the findings of the BRIDGE-MASH study, assessing clinical and economic outcomes in a cohort of patients with an unprecedented follow-up period of more than 40 years.
030
Hannes Hagström @liverepi.bsky.social · 21/11/2024
In Journal of Internal Medicine this week: Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease. onlinelibrary.wiley.com/doi/full/10....
onlinelibrary.wiley.com
<em>Journal of Internal Medicine</em> | Wiley Online Library
Background and objectives Statins are used for metabolic dysfunction-associated steatotic liver disease (MASLD) (NAFLD) treatment, but their role in this context is unclear. Genetic variants of pata...
020